img

Global Equine Rhinopneumonitis Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Equine Rhinopneumonitis Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Equine Rhinopneumonitis Vaccine can prevent Equine Rhinopneumonitis，viruses that are prevalent in horses and can cause outbreaks of respiratory disease.
Equine Rhinopneumonitis Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Equine Rhinopneumonitis Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Veterinary Pharmacy and Online Sale are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Equine Rhinopneumonitis Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Equine Rhinopneumonitis Vaccine key manufacturers include Zoetis, Nisseiken Co., Ltd., Boehringer Ingelheim, Santa Cruz Animal Health and Merck, etc. Zoetis, Nisseiken Co., Ltd., Boehringer Ingelheim are top 3 players and held % sales share in total in 2022.
Equine Rhinopneumonitis Vaccine can be divided into Live and Inactivated, etc. Live is the mainstream product in the market, accounting for % sales share globally in 2022.
Equine Rhinopneumonitis Vaccine is widely used in various fields, such as Veterinary Pharmacy, Online Sale and Others,, etc. Veterinary Pharmacy provides greatest supports to the Equine Rhinopneumonitis Vaccine industry development. In 2022, global % sales of Equine Rhinopneumonitis Vaccine went into Veterinary Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Equine Rhinopneumonitis Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Zoetis
Nisseiken Co., Ltd.
Boehringer Ingelheim
Santa Cruz Animal Health
Merck
Segment by Type
Live
Inactivated

Segment by Application


Veterinary Pharmacy
Online Sale
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Equine Rhinopneumonitis Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Equine Rhinopneumonitis Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Equine Rhinopneumonitis Vaccine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Equine Rhinopneumonitis Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Equine Rhinopneumonitis Vaccine introduction, etc. Equine Rhinopneumonitis Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Equine Rhinopneumonitis Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Equine Rhinopneumonitis Vaccine Market Overview
1.1 Equine Rhinopneumonitis Vaccine Product Overview
1.2 Equine Rhinopneumonitis Vaccine Market Segment by Type
1.2.1 Live
1.2.2 Inactivated
1.3 Global Equine Rhinopneumonitis Vaccine Market Size by Type
1.3.1 Global Equine Rhinopneumonitis Vaccine Market Size Overview by Type (2024-2034)
1.3.2 Global Equine Rhinopneumonitis Vaccine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Equine Rhinopneumonitis Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Equine Rhinopneumonitis Vaccine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Equine Rhinopneumonitis Vaccine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Equine Rhinopneumonitis Vaccine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Breakdown by Type (2024-2024)
2 Global Equine Rhinopneumonitis Vaccine Market Competition by Company
2.1 Global Top Players by Equine Rhinopneumonitis Vaccine Sales (2024-2024)
2.2 Global Top Players by Equine Rhinopneumonitis Vaccine Revenue (2024-2024)
2.3 Global Top Players by Equine Rhinopneumonitis Vaccine Price (2024-2024)
2.4 Global Top Manufacturers Equine Rhinopneumonitis Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Equine Rhinopneumonitis Vaccine Market Competitive Situation and Trends
2.5.1 Equine Rhinopneumonitis Vaccine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Equine Rhinopneumonitis Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Equine Rhinopneumonitis Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Equine Rhinopneumonitis Vaccine Market
2.8 Key Manufacturers Equine Rhinopneumonitis Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Equine Rhinopneumonitis Vaccine Status and Outlook by Region
3.1 Global Equine Rhinopneumonitis Vaccine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Equine Rhinopneumonitis Vaccine Historic Market Size by Region
3.2.1 Global Equine Rhinopneumonitis Vaccine Sales in Volume by Region (2024-2024)
3.2.2 Global Equine Rhinopneumonitis Vaccine Sales in Value by Region (2024-2024)
3.2.3 Global Equine Rhinopneumonitis Vaccine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Equine Rhinopneumonitis Vaccine Forecasted Market Size by Region
3.3.1 Global Equine Rhinopneumonitis Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Equine Rhinopneumonitis Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Equine Rhinopneumonitis Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Equine Rhinopneumonitis Vaccine by Application
4.1 Equine Rhinopneumonitis Vaccine Market Segment by Application
4.1.1 Veterinary Pharmacy
4.1.2 Online Sale
4.1.3 Others
4.2 Global Equine Rhinopneumonitis Vaccine Market Size by Application
4.2.1 Global Equine Rhinopneumonitis Vaccine Market Size Overview by Application (2024-2034)
4.2.2 Global Equine Rhinopneumonitis Vaccine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Equine Rhinopneumonitis Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Equine Rhinopneumonitis Vaccine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Equine Rhinopneumonitis Vaccine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Equine Rhinopneumonitis Vaccine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Breakdown by Application (2024-2024)
5 North America Equine Rhinopneumonitis Vaccine by Country
5.1 North America Equine Rhinopneumonitis Vaccine Historic Market Size by Country
5.1.1 North America Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Equine Rhinopneumonitis Vaccine Sales in Volume by Country (2024-2024)
5.1.3 North America Equine Rhinopneumonitis Vaccine Sales in Value by Country (2024-2024)
5.2 North America Equine Rhinopneumonitis Vaccine Forecasted Market Size by Country
5.2.1 North America Equine Rhinopneumonitis Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Equine Rhinopneumonitis Vaccine Sales in Value by Country (2024-2034)
6 Europe Equine Rhinopneumonitis Vaccine by Country
6.1 Europe Equine Rhinopneumonitis Vaccine Historic Market Size by Country
6.1.1 Europe Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Equine Rhinopneumonitis Vaccine Sales in Volume by Country (2024-2024)
6.1.3 Europe Equine Rhinopneumonitis Vaccine Sales in Value by Country (2024-2024)
6.2 Europe Equine Rhinopneumonitis Vaccine Forecasted Market Size by Country
6.2.1 Europe Equine Rhinopneumonitis Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Equine Rhinopneumonitis Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Equine Rhinopneumonitis Vaccine by Region
7.1 Asia-Pacific Equine Rhinopneumonitis Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Equine Rhinopneumonitis Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales in Value by Region (2024-2034)
8 Latin America Equine Rhinopneumonitis Vaccine by Country
8.1 Latin America Equine Rhinopneumonitis Vaccine Historic Market Size by Country
8.1.1 Latin America Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Equine Rhinopneumonitis Vaccine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Equine Rhinopneumonitis Vaccine Sales in Value by Country (2024-2024)
8.2 Latin America Equine Rhinopneumonitis Vaccine Forecasted Market Size by Country
8.2.1 Latin America Equine Rhinopneumonitis Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Equine Rhinopneumonitis Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Equine Rhinopneumonitis Vaccine by Country
9.1 Middle East and Africa Equine Rhinopneumonitis Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Equine Rhinopneumonitis Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Equine Rhinopneumonitis Vaccine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Equine Rhinopneumonitis Vaccine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Equine Rhinopneumonitis Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Equine Rhinopneumonitis Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Equine Rhinopneumonitis Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Zoetis
10.1.1 Zoetis Company Information
10.1.2 Zoetis Introduction and Business Overview
10.1.3 Zoetis Equine Rhinopneumonitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Zoetis Equine Rhinopneumonitis Vaccine Products Offered
10.1.5 Zoetis Recent Development
10.2 Nisseiken Co., Ltd.
10.2.1 Nisseiken Co., Ltd. Company Information
10.2.2 Nisseiken Co., Ltd. Introduction and Business Overview
10.2.3 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Products Offered
10.2.5 Nisseiken Co., Ltd. Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Santa Cruz Animal Health
10.4.1 Santa Cruz Animal Health Company Information
10.4.2 Santa Cruz Animal Health Introduction and Business Overview
10.4.3 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Products Offered
10.4.5 Santa Cruz Animal Health Recent Development
10.5 Merck
10.5.1 Merck Company Information
10.5.2 Merck Introduction and Business Overview
10.5.3 Merck Equine Rhinopneumonitis Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Merck Equine Rhinopneumonitis Vaccine Products Offered
10.5.5 Merck Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Equine Rhinopneumonitis Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Equine Rhinopneumonitis Vaccine Industrial Chain Analysis
11.4 Equine Rhinopneumonitis Vaccine Market Dynamics
11.4.1 Equine Rhinopneumonitis Vaccine Industry Trends
11.4.2 Equine Rhinopneumonitis Vaccine Market Drivers
11.4.3 Equine Rhinopneumonitis Vaccine Market Challenges
11.4.4 Equine Rhinopneumonitis Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Equine Rhinopneumonitis Vaccine Distributors
12.3 Equine Rhinopneumonitis Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Live
Table 2. Major Company of Inactivated
Table 3. Global Equine Rhinopneumonitis Vaccine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Equine Rhinopneumonitis Vaccine Sales by Type (2024-2024) & (K Units)
Table 5. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Equine Rhinopneumonitis Vaccine Sales by Type (2024-2024) & (US& Million)
Table 7. Global Equine Rhinopneumonitis Vaccine Market Share in Value by Type (2024-2024)
Table 8. Global Equine Rhinopneumonitis Vaccine Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Equine Rhinopneumonitis Vaccine Sales by Type (2024-2034) & (K Units)
Table 10. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Equine Rhinopneumonitis Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Equine Rhinopneumonitis Vaccine Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Equine Rhinopneumonitis Vaccine Sales by Type (2024-2024) & (K Units)
Table 15. North America Equine Rhinopneumonitis Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Equine Rhinopneumonitis Vaccine Sales (K Units) by Type (2024-2024)
Table 17. Europe Equine Rhinopneumonitis Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Equine Rhinopneumonitis Vaccine Sales (K Units) by Type (2024-2024)
Table 21. Latin America Equine Rhinopneumonitis Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Equine Rhinopneumonitis Vaccine Sales by Company (2024-2024) & (K Units)
Table 25. Global Equine Rhinopneumonitis Vaccine Sales Share by Company (2024-2024)
Table 26. Global Equine Rhinopneumonitis Vaccine Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Equine Rhinopneumonitis Vaccine Revenue Share by Company (2024-2024)
Table 28. Global Market Equine Rhinopneumonitis Vaccine Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Equine Rhinopneumonitis Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Equine Rhinopneumonitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Equine Rhinopneumonitis Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Equine Rhinopneumonitis Vaccine Market
Table 33. Key Manufacturers Equine Rhinopneumonitis Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Equine Rhinopneumonitis Vaccine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Equine Rhinopneumonitis Vaccine Sales by Region (2024-2024) & (K Units)
Table 37. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Equine Rhinopneumonitis Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Region (2024-2024)
Table 40. Global Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Equine Rhinopneumonitis Vaccine Sales by Region (2024-2034) & (K Units)
Table 42. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Equine Rhinopneumonitis Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Equine Rhinopneumonitis Vaccine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Equine Rhinopneumonitis Vaccine Sales by Application (2024-2024) & (K Units)
Table 48. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Equine Rhinopneumonitis Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Application (2024-2024)
Table 51. Global Equine Rhinopneumonitis Vaccine Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Equine Rhinopneumonitis Vaccine Sales by Application (2024-2034) & (K Units)
Table 53. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Equine Rhinopneumonitis Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Application (2024-2034)
Table 56. Global Equine Rhinopneumonitis Vaccine Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Equine Rhinopneumonitis Vaccine Sales by Application (2024-2024) (K Units)
Table 58. North America Equine Rhinopneumonitis Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Equine Rhinopneumonitis Vaccine Sales by Application (2024-2024) (K Units)
Table 60. Europe Equine Rhinopneumonitis Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Equine Rhinopneumonitis Vaccine Sales by Application (2024-2024) (K Units)
Table 64. Latin America Equine Rhinopneumonitis Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Equine Rhinopneumonitis Vaccine Sales by Country (2024-2024) & (K Units)
Table 68. North America Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Equine Rhinopneumonitis Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Country (2024-2024)
Table 71. North America Equine Rhinopneumonitis Vaccine Sales by Country (2024-2034) & (K Units)
Table 72. North America Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Equine Rhinopneumonitis Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Equine Rhinopneumonitis Vaccine Sales by Country (2024-2024) & (K Units)
Table 76. Europe Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Equine Rhinopneumonitis Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Equine Rhinopneumonitis Vaccine Sales by Country (2024-2034) & (K Units)
Table 80. Europe Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Equine Rhinopneumonitis Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Equine Rhinopneumonitis Vaccine Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Equine Rhinopneumonitis Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Equine Rhinopneumonitis Vaccine Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Equine Rhinopneumonitis Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Country (2024-2034)
Table 107. Zoetis Company Information
Table 108. Zoetis Introduction and Business Overview
Table 109. Zoetis Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Zoetis Equine Rhinopneumonitis Vaccine Product
Table 111. Zoetis Recent Development
Table 112. Nisseiken Co., Ltd. Company Information
Table 113. Nisseiken Co., Ltd. Introduction and Business Overview
Table 114. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product
Table 116. Nisseiken Co., Ltd. Recent Development
Table 117. Boehringer Ingelheim Company Information
Table 118. Boehringer Ingelheim Introduction and Business Overview
Table 119. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product
Table 121. Boehringer Ingelheim Recent Development
Table 122. Santa Cruz Animal Health Company Information
Table 123. Santa Cruz Animal Health Introduction and Business Overview
Table 124. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product
Table 126. Santa Cruz Animal Health Recent Development
Table 127. Merck Company Information
Table 128. Merck Introduction and Business Overview
Table 129. Merck Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Merck Equine Rhinopneumonitis Vaccine Product
Table 131. Merck Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Equine Rhinopneumonitis Vaccine Market Trends
Table 135. Equine Rhinopneumonitis Vaccine Market Drivers
Table 136. Equine Rhinopneumonitis Vaccine Market Challenges
Table 137. Equine Rhinopneumonitis Vaccine Market Restraints
Table 138. Equine Rhinopneumonitis Vaccine Distributors List
Table 139. Equine Rhinopneumonitis Vaccine Downstream Customers
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Equine Rhinopneumonitis Vaccine Product Picture
Figure 2. Global Equine Rhinopneumonitis Vaccine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Equine Rhinopneumonitis Vaccine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Equine Rhinopneumonitis Vaccine Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Live
Figure 6. Global Live Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Inactivated
Figure 8. Global Inactivated Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Equine Rhinopneumonitis Vaccine Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Equine Rhinopneumonitis Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Equine Rhinopneumonitis Vaccine Revenue in 2022
Figure 23. Equine Rhinopneumonitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Veterinary Pharmacy
Figure 25. Global Veterinary Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Online Sale
Figure 27. Global Online Sale Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Equine Rhinopneumonitis Vaccine Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Application in 2022 & 2034
Figure 32. North America Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. North America Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Europe Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Europe Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Latin America Equine Rhinopneumonitis Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Equine Rhinopneumonitis Vaccine Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Equine Rhinopneumonitis Vaccine Manufacturing Cost Structure
Figure 43. Equine Rhinopneumonitis Vaccine Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries